227 related articles for article (PubMed ID: 26511742)
1. Clinical Utility of Laboratory Detection of Clostridium difficile Strain BI/NAP1/027.
Kociolek LK; Gerding DN
J Clin Microbiol; 2016 Jan; 54(1):19-24. PubMed ID: 26511742
[TBL] [Abstract][Full Text] [Related]
2. Clostridium difficile infection (CDI) severity and outcome among patients infected with the NAP1/BI/027 strain in a non-epidemic setting.
Scardina T; Labuszewski L; Pacheco SM; Adams W; Schreckenberger P; Johnson S
Infect Control Hosp Epidemiol; 2015 Mar; 36(3):280-6. PubMed ID: 25695169
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic pitfalls in Clostridium difficile infection.
Planche T; Wilcox MH
Infect Dis Clin North Am; 2015 Mar; 29(1):63-82. PubMed ID: 25595842
[TBL] [Abstract][Full Text] [Related]
4. How to: diagnose infection caused by Clostridium difficile.
Gateau C; Couturier J; Coia J; Barbut F
Clin Microbiol Infect; 2018 May; 24(5):463-468. PubMed ID: 29269092
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Multilocus Sequence Typing and the Xpert C. difficile/Epi Assay for Identification of Clostridium difficile 027/NAP1/BI.
McMillen T; Kamboj M; Babady NE
J Clin Microbiol; 2016 Mar; 54(3):775-8. PubMed ID: 26699700
[TBL] [Abstract][Full Text] [Related]
6. [The use of molecular methods in the diagnosis of Clostridium difficile infections].
Dulny G; Nurzyńska G; de Walthoffen SW; Kraśnicka A; Młynarczyk G
Med Dosw Mikrobiol; 2013; 65(2):111-8. PubMed ID: 24180138
[TBL] [Abstract][Full Text] [Related]
7. Comparison of eight commercial enzyme immunoassays for the detection of Clostridium difficile from stool samples and effect of strain type.
René P; Frenette CP; Schiller I; Dendukuri N; Brassard P; Fenn S; Loo VG
Diagn Microbiol Infect Dis; 2012 May; 73(1):94-6. PubMed ID: 22424900
[TBL] [Abstract][Full Text] [Related]
8. Impact of the NAP-1 strain on disease severity, mortality, and recurrence of healthcare-associated Clostridium difficile infection.
Bauer KA; Johnston JEW; Wenzler E; Goff DA; Cook CH; Balada-Llasat JM; Pancholi P; Mangino JE
Anaerobe; 2017 Dec; 48():1-6. PubMed ID: 28645479
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of the Clostridium difficile BI/NAP1/027 strain across the United States Veterans Health Administration.
Giancola SE; Williams RJ; Gentry CA
Clin Microbiol Infect; 2018 Aug; 24(8):877-881. PubMed ID: 29174729
[TBL] [Abstract][Full Text] [Related]
10. Direct detection of Clostridium difficile 027 in diarrhoeal stool samples.
Clark M; Towner KJ
J Hosp Infect; 2011 Sep; 79(1):94-5. PubMed ID: 21783275
[No Abstract] [Full Text] [Related]
11. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile-associated diarrhea.
Peterson LR; Manson RU; Paule SM; Hacek DM; Robicsek A; Thomson RB; Kaul KL
Clin Infect Dis; 2007 Nov; 45(9):1152-60. PubMed ID: 17918076
[TBL] [Abstract][Full Text] [Related]
12. Novel portable platform for molecular detection of toxigenic Clostridium difficile in faeces: a diagnostic accuracy study.
Hirvonen JJ; Matero P; Siebert C; Kauppila J; Vuento R; Tuokko H; Boisset S
Eur J Clin Microbiol Infect Dis; 2017 May; 36(5):783-789. PubMed ID: 27988815
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of Clostridium difficile infection.
Musher DM; Stager C
Clin Infect Dis; 2012 Jun; 54(11):1675-6. PubMed ID: 22503848
[No Abstract] [Full Text] [Related]
14. Overcoming barriers to effective recognition and diagnosis of Clostridium difficile infection.
Wilcox MH
Clin Microbiol Infect; 2012 Dec; 18 Suppl 6():13-20. PubMed ID: 23121550
[TBL] [Abstract][Full Text] [Related]
15. Performance assessment of the BD MAX Cdiff assay in comparison to Xpert C. difficile assay in a setting with very low prevalence of toxigenic Clostridium difficile PCR ribotype 027.
Chiang D; Ng S; La MV; Jureen R; Lin RT; Teo JW
Anaerobe; 2014 Dec; 30():156-8. PubMed ID: 25305151
[TBL] [Abstract][Full Text] [Related]
16. PCR based detection of tcdCΔ117 in Clostridium difficile infection identifies patients at risk for recurrence - A hospital-based prospective observational study.
Jazmati N; Hain O; Hellmich M; Plum G; Kaasch A
Anaerobe; 2019 Jun; 57():39-44. PubMed ID: 30878603
[TBL] [Abstract][Full Text] [Related]
17. The Clinical and Laboratory Impact of Upgrading Clostridioides (formerly Clostridium) difficile Infection Testing from Routine to Molecular Based-Algorithm: an Observational Case-Study from the Eastern Province, Saudi Arabia.
Alnimr A; Alwazzeh MJ; Al-Ameer A
Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414736
[TBL] [Abstract][Full Text] [Related]
18. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and illumigene C. difficile.
Viala C; Le Monnier A; Maataoui N; Rousseau C; Collignon A; Poilane I
J Microbiol Methods; 2012 Aug; 90(2):83-5. PubMed ID: 22565213
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples.
Verhoeven PO; Carricajo A; Pillet S; Ros A; Fonsale N; Botelho-Nevers E; Lucht F; Berthelot P; Pozzetto B; Grattard F
J Microbiol Methods; 2013 Jul; 94(1):58-60. PubMed ID: 23643507
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of Clostridium difficile infection: the molecular approach.
Eckert C; Jones G; Barbut F
Future Microbiol; 2013 Dec; 8(12):1587-98. PubMed ID: 24266358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
